期刊文献+

卡维地洛对急性病毒性心肌炎小鼠TNF-α,MMP-3及TIMP-1表达的影响 被引量:4

Effect of carvedilol on expression of TNF-α,MMP-3 and TIMP-1 in mice with acute viral myocarditis
原文传递
导出
摘要 目的:研究卡维地洛对急性柯萨奇B3(CVB3)病毒性心肌炎小鼠的肿瘤坏死因子-α(TNFα-)、基质金属蛋白酶-3(MMP-3)及组织型基质金属蛋白酶抑制因子-1(TIMP-1)表达水平的影响。方法:将80只雄性Balb/C小鼠随机分为3组:正常对照组(n=20),心肌炎组(n=30),卡维地洛组(n=30)。后2组经腹腔接种CVB3诱发急性VMC,感染24 h后,卡维地洛组小鼠灌胃给予卡维地洛10 m·gkg-1·d-1,连续14 d。于接种d 14随机从各组抽取8只小鼠取血后处死并留取心脏等标本。比较干预组与对照组的心肌病理改变,采用ELISA法检测血清TNFα-,采用RT-PCR法检测心肌MMP-3及TIMP-1 mRNA的表达。结果:与心肌炎组比较,卡维地洛组心肌病理损伤明显减轻;与正常组比较,病毒性心肌炎小鼠血清TNFα-明显升高,心肌MMP-3表达明显上调,TIMP-1表达明显下调;卡维地洛干预后小鼠血清TNFα-明显下降,心肌MMP-3表达明显下调,TIMP-1表达明显上调。结论:卡维地洛通过抑制TNFα-水平、下调MMP-3的表达、以及上调TIMP-1的表达,减轻心肌炎小鼠的心肌损害。 Objective:To determine the effect of carvedilol on expression of TNF-α,MMP-3 and TIMP-1 in mice with acute viral myocarditis induced by coxsackievirus B3 virus(CVB3) infection.Methods: BALB/C mice were intraperitoneally inoculated with CVB3 to induce myocarditis.From 24 h after infection,carvedilol was orally administered at a dose of 10 mg·kg-1·d-1 for 14 d continuously.Virus infection and normal controls were treated with same volume of PBS.Then,the myocardial histopathological changes,HW/BW ratio,serum TNF-α,mRNA expression of myocardial MMP-3 and TIMP-1 were determined.Results: Carvedilol significantly attenuated myocardial lesions and decreased HW/BW ratio.It also remarkably decreased serum TNF-α,down-regulated mRNA expression of MMP-3,and up-regulated mRNA expression of TIMP-1 as compared with myocarditis control.Conclusion: Carvedilol protects against CVB3-induced viral myocarditis in mice.Carvedilol exerts its beneficial effect by down-regulating MMP-3 mRNA expression and serum TNF-α,and up-regulating TIMP-1 mRNA expression.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第8期736-739,共4页 Chinese Journal of New Drugs
基金 浙江省自然科学基金(Y2100551) 温州市科技局基金(Y20080124)
  • 相关文献

参考文献8

  • 1SIVASUBR.AMANIAN N, COKER M, KURRELMEYER K, et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor[ J ]. Circulation, 2001, 104 (7): 826-831,.
  • 2DULIN B, ABAHAM WT. Pharmacology of carvedilol[J]. Am J Cardiol, 2004, 93 (9A) : 3B-6B.
  • 3LI YC, GE LS, YANG PL, et al. Carvedilol treatment ameliorates acute coxsackievirus B3-induced myoearditis associated with oxidative stress reduction[J]. Eur J Pharmacol, 2010,640 (1 -3): 112 -116.
  • 4LI YC, GE LS, REN JH, et al. Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myoearditis [ J ]. J Cardiovasc Pharmacol,2008, 51 (1) : 92 -98.
  • 5COOPER LT JR. Myocarditis [ J]. N Engl J Med, 2009, 360 (15) : 1526 -1538.
  • 6LI YY, FENG YQ, KADCKAMI T, et al. Myocardial extracellular matrix remodeling in transgenic mice over expressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy[J]. Proc Natl Acad Sci USA, 2000, 97 (23): 12746 - 12753.
  • 7LI J, SCHWIMMBECK PL, TSCHOPE C, et al. Collagen degradation in a routine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction[ J]. Cardiovasc Res, 2002, 56(2) : 235 -247.
  • 8ETOH T, JOFFS C, DESCHAMPS AI, et al. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs[J]. Am J Physiol Heart Circ Physiol, 2001, 281 (3) : H987 - H99d.

同被引文献30

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部